Monitoring of the renal function changes during chemotherapy based on high-dose cisplatin in patients with lung cancer.
- Author:
Li REN
1
;
Qinghua ZHOU
;
Mei HOU
;
Meng QIU
;
Jianping HE
;
Hui CHEN
Author Information
- Publication Type:Journal Article
- From: Chinese Journal of Lung Cancer 2002;5(5):363-365
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUNDTo study the methods for monitoring nephrotoxicity of cisplatin in lung cancer chemotherapy.
METHODSThe serum urea nitrogen (BUN), creatine (Cr) and urine β2-microglobulin ( β2-MG),α1-microglobulin(α1-MG), albumin (Alb), transferrin (TRF), and retinol-binding-protein (RBP) were measured dynamically in 61 patients with lung cancer who received high-dose chemotherapy with DDP (80- 120 mg/m2) (totally 114 cycles), and some indexes of early nephrotxcity were screened.
RESULTSAt the early stage of chemotherapy (d1-5), the abnormal rates of urine β2-MG and α1-MG were much more predominant than those of other indexes (P < 0.001). The abnormal rates of serum BUN and Cr were increased significantly in the late period of chemotherapy (d10). There were abnormal elevation of urine β2-MG and/or α1-MG at the early stage of chemotherapy for the patients whose serum BUN and creatine were all abnormal at the late stage.
CONCLUSIONSThe urine β2-MG and /or α1-MG might be the valuable indexes for early diagnosis of nephrotoxicity in lung cancer chemotherapy with cisplatin.